ADVERTISEMENT
  • Home
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Editorial Guidelines
Tuesday, August 9, 2022
Life Care News
  • Home
  • Business
    • BusinessWire
    • GlobeNewswire
    • Banking
  • News

    Akriti Kakar, Asees Kaur, Neha Dhupia, Shruti Seth and Ali Asgar with their Presence Makes EEMAGINE 2022 Larger than Life

    Archies Limited Launches the ‘Rishte Kare Mazboot’ Campaign for Raksha Bandhan RishteKareMazboot

    RBI Hikes Repo Rate: How Real Estate Developers Reacted

    Parliamentarians Appeal for Strengthening of Tobacco Control Laws to Save GenNext

    Indian Bank Inks MoU with SRM University-AP to Lend up to 50 Crores for Start-ups

    Kameswari Jewellers Launches State of Art Jewellery Store in Jubilee Hills Hyderabad

    The Great India Run Flags-off from Srinagar

    Zeco Aircon to Create a Cross-Infection Safe Space at ITC Hotel Properties

    Travel Fintech Startup SanKash Reveals How India Travel During Long Weekends

    ABP Majha Concludes its Annual Felicitation Ceremony Majha Sanman Puraskar 2022

    Trending Tags

    • Donald Trump
    • Future of News
    • Climate Change
    • Market Stories
    • Election Results
    • Flat Earth
    • Startups
    • Feature News
    • Energy
    • Real Estate
    • Environment
    • Uncategorized
  • Tech

    Rohde & Schwarz Announces Comprehensive Test Solutions for 5G NR Release 17

    Rohde & Schwarz Participates in 6G-ANNA, a Lighthouse Project to Advance 6G in Germany

    Rohde & Schwarz Announces On-Wafer Device Characterization Test Solution

    Granite River Labs and Rohde & Schwarz Extend Partnership

    Rohde & Schwarz Extends R&S ESW EMI Test Receiver Bandwidth to 1 GHz

    Rohde & Schwarz and MediaTek verify 5G LBS Release 16 features on the R&S TS-LBS test solution

    NORD Duodrive Now With Powers Of Up To 3 Kw Patented Geared Motor For Ultimate Energy Efficiency

    MTAR Technologies Limited Receives Orders of USD 22.12 Million in Clean Energy

    Rohde & Schwarz Offers New Ultra-Wideband Test Solution Validated for FiRa Consortium PHY Conformance

    Power League Gaming Names Langoor as New Digital Transformation Agency Partner

    Trending Tags

    • Flat Earth
    • Sillicon Valley
    • Mr. Robot
    • MotoGP 2017
    • Golden Globes
    • Future of News
  • Entertainment

    People Matters TechHR 2022 Brings Fresh Eyes to the World of HR

    Woxsen University bestows Chair Professorships in honour of International Experts

    Enthusiast Gaming Provides Update on Senior Management Team

    Baba Arts Limited Launches Independent Music Label BABA BEATS

    The “Picturesque and Dynamic Zhejiang” Global Short Video Competition Launches

    GIGABYTE Releases 600 series BIOS updates ready for Intel’s upcoming new-gen processors

    Jack.org and Born This Way Foundation Celebrate Be There

    Bachpan Ki Mitrata Sabse Bemisaal!

    Golf Equipment Market Size is projected to reach USD 15.44

    Highly Anticipated Original Graphic Novel Series The Legion

    • Lifestyle

      Brij Hotels has Added Brij Gaj Kesri Bikaner to its Portfolio The Stunning Boutique Hotel, is Set to Open its Doors in October 2022

      OYO Announces Independence Day Explore the Unexplored Offer with Stays Starting INR 399/-

      A Brand New Initiative for Sustainable Fashion by Prabha Khaitan Foundation and Grammy Award Winner Ricky Kej

      Aditya Birla Fashion and Retail Posts Highest Ever Q1 Sales with 39 percent Revenue Growth over pre-COVID Levels; EBITDA Grew 51 percent over the Period to Rs. 500 Cr.

      Malabar Gold and Diamonds Wins Two Awards at the 48th IGJA 2021

      Bangalore Watch Company™ Launches a Limited Edition Watch to Commemorate the 25th Anniversary of Indian Air Force Suryakiran Team

      Misahna Launches Fashion Label in India Showcases Bespoke Collection at a Fashion Show

      Haut Monde Mrs India Worldwide 2022 Grand Finale Concluded in U.A.E.

      Vision Board Studio – Making the Jewelry Industry Across the Globe Dazzle through Visual Merchandising

      Dickey’s Barbecue Pit’s Summer Catering Contest

      Trending Tags

      • Golden Globes
      • Mr. Robot
      • MotoGP 2017
      • Climate Change
      • Flat Earth
    • Fashion
    • Travel
  • Health
    • Food
  • Education
    • Books
  • Technology
  • Automobile
  • Sports
    • Olympic
No Result
View All Result
Life Care News
  • Home
  • Business
    • BusinessWire
    • GlobeNewswire
    • Banking
  • News

    Akriti Kakar, Asees Kaur, Neha Dhupia, Shruti Seth and Ali Asgar with their Presence Makes EEMAGINE 2022 Larger than Life

    Archies Limited Launches the ‘Rishte Kare Mazboot’ Campaign for Raksha Bandhan RishteKareMazboot

    RBI Hikes Repo Rate: How Real Estate Developers Reacted

    Parliamentarians Appeal for Strengthening of Tobacco Control Laws to Save GenNext

    Indian Bank Inks MoU with SRM University-AP to Lend up to 50 Crores for Start-ups

    Kameswari Jewellers Launches State of Art Jewellery Store in Jubilee Hills Hyderabad

    The Great India Run Flags-off from Srinagar

    Zeco Aircon to Create a Cross-Infection Safe Space at ITC Hotel Properties

    Travel Fintech Startup SanKash Reveals How India Travel During Long Weekends

    ABP Majha Concludes its Annual Felicitation Ceremony Majha Sanman Puraskar 2022

    Trending Tags

    • Donald Trump
    • Future of News
    • Climate Change
    • Market Stories
    • Election Results
    • Flat Earth
    • Startups
    • Feature News
    • Energy
    • Real Estate
    • Environment
    • Uncategorized
  • Tech

    Rohde & Schwarz Announces Comprehensive Test Solutions for 5G NR Release 17

    Rohde & Schwarz Participates in 6G-ANNA, a Lighthouse Project to Advance 6G in Germany

    Rohde & Schwarz Announces On-Wafer Device Characterization Test Solution

    Granite River Labs and Rohde & Schwarz Extend Partnership

    Rohde & Schwarz Extends R&S ESW EMI Test Receiver Bandwidth to 1 GHz

    Rohde & Schwarz and MediaTek verify 5G LBS Release 16 features on the R&S TS-LBS test solution

    NORD Duodrive Now With Powers Of Up To 3 Kw Patented Geared Motor For Ultimate Energy Efficiency

    MTAR Technologies Limited Receives Orders of USD 22.12 Million in Clean Energy

    Rohde & Schwarz Offers New Ultra-Wideband Test Solution Validated for FiRa Consortium PHY Conformance

    Power League Gaming Names Langoor as New Digital Transformation Agency Partner

    Trending Tags

    • Flat Earth
    • Sillicon Valley
    • Mr. Robot
    • MotoGP 2017
    • Golden Globes
    • Future of News
  • Entertainment

    People Matters TechHR 2022 Brings Fresh Eyes to the World of HR

    Woxsen University bestows Chair Professorships in honour of International Experts

    Enthusiast Gaming Provides Update on Senior Management Team

    Baba Arts Limited Launches Independent Music Label BABA BEATS

    The “Picturesque and Dynamic Zhejiang” Global Short Video Competition Launches

    GIGABYTE Releases 600 series BIOS updates ready for Intel’s upcoming new-gen processors

    Jack.org and Born This Way Foundation Celebrate Be There

    Bachpan Ki Mitrata Sabse Bemisaal!

    Golf Equipment Market Size is projected to reach USD 15.44

    Highly Anticipated Original Graphic Novel Series The Legion

    • Lifestyle

      Brij Hotels has Added Brij Gaj Kesri Bikaner to its Portfolio The Stunning Boutique Hotel, is Set to Open its Doors in October 2022

      OYO Announces Independence Day Explore the Unexplored Offer with Stays Starting INR 399/-

      A Brand New Initiative for Sustainable Fashion by Prabha Khaitan Foundation and Grammy Award Winner Ricky Kej

      Aditya Birla Fashion and Retail Posts Highest Ever Q1 Sales with 39 percent Revenue Growth over pre-COVID Levels; EBITDA Grew 51 percent over the Period to Rs. 500 Cr.

      Malabar Gold and Diamonds Wins Two Awards at the 48th IGJA 2021

      Bangalore Watch Company™ Launches a Limited Edition Watch to Commemorate the 25th Anniversary of Indian Air Force Suryakiran Team

      Misahna Launches Fashion Label in India Showcases Bespoke Collection at a Fashion Show

      Haut Monde Mrs India Worldwide 2022 Grand Finale Concluded in U.A.E.

      Vision Board Studio – Making the Jewelry Industry Across the Globe Dazzle through Visual Merchandising

      Dickey’s Barbecue Pit’s Summer Catering Contest

      Trending Tags

      • Golden Globes
      • Mr. Robot
      • MotoGP 2017
      • Climate Change
      • Flat Earth
    • Fashion
    • Travel
  • Health
    • Food
  • Education
    • Books
  • Technology
  • Automobile
  • Sports
    • Olympic
No Result
View All Result
Life Care News
No Result
View All Result
ADVERTISEMENT
Home Health

U.S. Food and Drug Administration Approves Camzyos

by GlobeNewswire
29/04/2022
in Health
250 3
0
492
SHARES
1.4k
VIEWS
Share on FacebookShare on TwitterShare on WhatsApp
ADVERTISEMENT

SHANGHAI and PRINCETON, N.J., April 29, 2022 (GLOBE NEWSWIRE) — LianBio’s (Nasdaq: LIAN) partner, Bristol Myers Squibb, announced yesterday that the U.S. Food and Drug Administration (FDA) approved Camzyos™ (mavacamten, 2.5 mg, 5 mg, 10 mg and 15 mg capsules) for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (obstructive HCM) to improve functional capacity and symptoms. Camzyos is the first and only FDA-approved allosteric and reversible inhibitor selective for cardiac myosin that targets the underlying pathophysiology of obstructive HCM.

LianBio licensed rights from MyoKardia, now a wholly owned subsidiary of Bristol Myers Squibb, in August 2020 for the development and commercialization of Camzyos in Mainland China, Hong Kong, Macau, Taiwan, Thailand and Singapore. LianBio is currently conducting EXPLORER-CN, a Phase 3 multicenter, double-blind, randomized, placebo-controlled registrational study designed to evaluate the safety and efficacy of mavacamten in Chinese patients with symptomatic obstructive HCM. Camzyos was granted Breakthrough Therapy Designation in China for the treatment of patients with obstructive HCM.

“We congratulate Bristol Myers Squibb on receiving U.S. FDA approval for Camzyos in patients with symptomatic NYHA class II-III obstructive HCM,” said Yizhe Wang, Ph.D., chief executive officer of LianBio. “Obstructive HCM is a debilitating heart disease with significant unmet medical need in China. We estimate there are approximately 1.1 million to 2.8 million patients with HCM in China, and approximately two-thirds of those patients have symptomatic obstructive HCM. We are excited to continue our strategic collaboration and further development of Camzyos in China and other Asian markets to help bring this promising treatment to patients in need.”

Advertisement. Scroll to continue reading.

About Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a chronic, progressive disease in which excessive contraction of the heart muscle and reduced ability of the left ventricle to fill can lead to the development of debilitating symptoms and cardiac dysfunction. HCM is estimated to affect one in every 500 people globally.

The most frequent cause of HCM is mutations in the heart muscle proteins of the sarcomere. In both obstructive and non-obstructive HCM patients, exertion can result in fatigue or shortness of breath, interfering with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risks of atrial fibrillation, stroke, heart failure and sudden cardiac death.

ADVERTISEMENT

About Camzyos
Camzyos™ (mavacamten) is the first and only cardiac myosin inhibitor approved by the FDA indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive HCM to improve functional capacity and symptoms. Camzyos is an allosteric and reversible inhibitor selective for cardiac myosin. Camzyos modulates the number of myosin heads that can enter “on actin” (power generating) states, thus reducing the probability of force producing (systolic) and residual (diastolic) cross-bridge formation. Excess myosin actin cross bridge formation and dysregulation of the super relaxed state are mechanistic hallmarks of HCM. Camzyos shifts the overall myosin population towards an energy sparing, recruitable, super relaxed state. In HCM patients, myosin inhibition with Camzyos reduces dynamic left ventricular outflow tract (LVOT) obstruction and improves cardiac filling pressures.

Advertisement. Scroll to continue reading.

About LianBio
LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications. LianBio is establishing an international infrastructure to position the company as a partner of choice with a platform to provide access to China and other Asian markets. For more information, please visit www.lianbio.com.

Advertisement. Scroll to continue reading.
ADVERTISEMENT
ADVERTISEMENT

Cautionary Note Regarding Forward-Looking Statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute forward-looking statements. The words “continue,” “estimate,” “potential” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements in this press release include, but are not limited to, statements concerning the Company’s plans and expectations with respect to its ability to develop and bring Camzyos to patients in Asia. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the Company’s ability to successfully initiate and conduct its planned clinical trials and complete such clinical trials and obtain results on its expected timelines, or at all; the Company’s plans to leverage data generated in its partners’ global registrational trials and clinical development programs to obtain regulatory approval and maximize patient reach for its product candidates; the Company’s ability to identify new product candidates and successfully acquire such product candidates from third parties; competition from other biotechnology and pharmaceutical companies; general market conditions; the impact of changing laws and regulations and those risks and uncertainties described in LianBio’s filings with the U.S. Securities and Exchange Commission (SEC), including LianBio’s Annual Report on Form 10-K for the year ended December 31, 2021 and subsequent filings with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and LianBio specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Readers should not rely upon this information as current or accurate after its publication date.

For investor inquiries, please contact:
Elizabeth Anderson, VP Communications and Investor Relations
E: elizabeth.anderson@lianbio.com
T: +1 646 655 8390

For media inquiries, please contact:
Katherine Smith, CanaleComm
E: katherine.smith@canalecomm.com
T: +1 619 849 5378

Tags: $LIANadministrationApprovesCamzyosDrugFoodLianBioNasdaq:LIAN
Share197Tweet123Send
ADVERTISEMENT
Previous Post

Foreverise Team is launching the first watch-to-earn

Next Post

Paychex Declares 20% Increase in Quarterly Dividend

GlobeNewswire

GlobeNewswire

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Next Post

Paychex Declares 20% Increase in Quarterly Dividend

  • Trending
  • Comments
  • Latest

GreenCell Mobility Unveils ‘NueGo’ – First Pan-India Intercity Electric Mobility Coach Brand

22/04/2022

Sinch AB (publ) has published its Annual Report for 2021

22/04/2022

HarperCollins Presents THE RESILIENT SOCIETY: Economics After Covid by Markus Brunnermeier

22/04/2022

Mind Wars To Organise Mumbai Debate Championship 2021 : Zee Entertainment

ABP Network celebrated Doctors Day with special programming initiatives

Coca-Cola India appointment Devyani Rajya Laxmi Rana as Vice President of Public Affairs for India and Southwest Asia

Coca-Cola India appointment Devyani Rajya Laxmi Rana as Vice President of Public Affairs for India and Southwest Asia

Brij Hotels has Added Brij Gaj Kesri Bikaner to its Portfolio The Stunning Boutique Hotel, is Set to Open its Doors in October 2022

09/08/2022

Indian Ice-Cream Manufacturers’ Association (IICMA) met with Finance Minister Nirmala Sitharaman to discuss GST rates on supply of ice cream by ice cream parlours in India

09/08/2022

Honda BigWing Expands in Mid-Size Segment with The All-New Powerful, Sporty & Aggressive – CB300F

09/08/2022
ADVERTISEMENT
ADVERTISEMENT
Life Care News

Copyright © 2015 - 2021 Lifecarenews.in

LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283

  • Home
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Editorial Guidelines

Follow Us

No Result
View All Result
  • Home
  • Business
    • BusinessWire
    • GlobeNewswire
    • Banking
  • News
    • Startups
    • Feature News
    • Energy
    • Real Estate
    • Environment
    • Uncategorized
  • Tech
  • Entertainment
    • Lifestyle
    • Fashion
    • Travel
  • Health
    • Food
  • Education
    • Books
  • Technology
  • Automobile
  • Sports
    • Olympic

Copyright © 2015 - 2021 Lifecarenews.in

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Go to mobile version